Navigation Links
World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org
Date:7/29/2014

Dallas, Texas (PRWEB) July 29, 2014

PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market report is an essential source of information and analysis on the global biosimilars industry. Using detailed company data, financial analysis, corporate strategy, and market trends analysis, GlobalData provides in-depth analysis of the current and future growth drivers of the biosimilars industry. The report discusses the various regulatory frameworks under which biosimilars are currently reviewed and regulated. Furthermore, it discusses the key factors shaping and driving the biosimilars business, and provides insights on the competitive landscape and emerging strategies expected to significantly influence the market positions of companies currently involved in the development and commercialization of biosimilars.

The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking the overall biologics market value from $162 billion in 2013 to more than $262 billion by 2019.

Complete report details at http://www.marketoptimizer.org/pharmasphere-regulatory-frameworks-and-product-pipelines-in-the-global-biosimilars-market.html.

Overview of Key Players in Global Biosimilars Market:

  •     Hospira
  •     Actavis
  •     Pfizer
  •     Sandoz
  •     Stada Arzneimittel
  •     Gedeon Richter
  •     Kyowa Hakko Kirin Co. Ltd.
  •     JCR Pharmaceuticals
  •     Biocon
  •     Dr. Reddy’s Laboratories
  •     Ranbaxy Laboratories
  •     Reliance Life Sciences
  •     Cipla
  •     Celltrion
  •     Hanwha Chemical
  •     Samsung Bioepis
  •     LG Life Sciences
  •     3SBio
  •     Shandong Kexing Bioproducts

Key Questions Answered

  •     What are the drivers of the global biosimilars industry?
  •     Who are the top players involved in the development of biosimilars in the developed markets of Europe and the US, as well as in emerging markets, including India and China?
  •     What are the major barriers to entry into the biosimilars industry?
  •     What specific strategies are companies utilizing to combat some of the challenges currently facing the development of the global biosimilars industry?
  •     What is the current state of biosimilars regulation in the EU, US, Japan, India, China, and South Korea?

Order a purchase copy at http://www.marketoptimizer.org/contacts/purchase?rname=8467.

“PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market”, provides strategic analysis of the global biosimilars industry. It discusses key market trends, regulatory requirements in various markets, recent deals activity and trends, as well as describes the operations strategy of these companies. Furthermore, it includes a geographical segmentation of various markets including the EU and US, as well as emerging markets such as India providing in-depth analysis of these markets’ regulatory framework, key domestic players and their biosimilar pipelines, and strategic outlook.

Scope

  •     The report provides analysis of the key drivers and trends shaping the global biosimilars industry.
  •     The report discusses the biosimilar regulatory landscape of various markets including developed markets of the US and EU, as well as emerging markets such as China and India. Furthermore, it identifies key domestic players in the various markets discussed and provides analysis of their strategy, manufacturing capacity, and clinical pipeline.
  •     The report contains expert insights on the corporate strategies of current and prospective players in the global biosimilars industry.
  •     The report contains a special case study on Teva Pharmaceutical Industries’ biosimilars business, including an in-depth SWOT analysis of the company.

Reasons to buy

  •     Understand the frameworks under which biosimilars are currently being reviewed and regulated across various developed and emerging markets
  •      Identify the key domestic players in various biosimilar markets, including South Korea, Japan and emerging markets such as India and China
  •     Understand the key drivers and trends in the global biosimilars industry
  •     Analyze and track the strategies that companies are using to enter and/or strengthen their position in the rapidly evolving biosimilars industry, as well as efforts being made by innovator companies like Amgen to protect their market position
  •     Use this information as an independent source for your due diligence and transaction strategy

Explore more reports on Pharmaceuticals industry at http://www.marketoptimizer.org/category/life-sciences/pharmaceuticals.

About Us:
MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/global-biosimilars-market/analysis-forecasts-2019/prweb12054403.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution
2. One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals
3. World’s Largest Uterine Fibroid Removed from Patient
4. Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld
5. Study tracks worldwide spread of beneficial blood cell gene variant
6. Living with a Disability Magazine Marks World Hepatitis Day on July 28 with New Article on Disabling Digestive Disorders
7. Inspiring Senior Athlete Lands Third World Title in One Year
8. Coffee and Tea Production in Canada Industry Market Research Report Now Available from IBISWorld
9. Cigarette and Tobacco Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld
10. Training Mask LLC Announces the Signing of World-Renowned Coach Brian MacKenzie
11. Setting A New High Jump World Record In Zensah® Compression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: